Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity (2014)
Source: Memórias do Instituto Oswaldo Cruz. Unidade: IQ
Subjects: DOENÇA DE CHAGAS, DIVERSIDADE GENÉTICA, TRYPANOSOMA CRUZI
ABNT
ZINGALES, Bianca et al. Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity. Memórias do Instituto Oswaldo Cruz, v. 109, n. 6, p. 828-833, 2014Tradução . . Disponível em: https://doi.org/10.1590/0074-0276140156. Acesso em: 01 jun. 2024.APA
Zingales, B., Miles, M. A., Moraes, C. B., Luquetti, A., Guhl, F., Schijman, A. G., & Ribeiro, I. (2014). Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity. Memórias do Instituto Oswaldo Cruz, 109( 6), 828-833. doi:10.1590/0074-0276140156NLM
Zingales B, Miles MA, Moraes CB, Luquetti A, Guhl F, Schijman AG, Ribeiro I. Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity [Internet]. Memórias do Instituto Oswaldo Cruz. 2014 ; 109( 6): 828-833.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1590/0074-0276140156Vancouver
Zingales B, Miles MA, Moraes CB, Luquetti A, Guhl F, Schijman AG, Ribeiro I. Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity [Internet]. Memórias do Instituto Oswaldo Cruz. 2014 ; 109( 6): 828-833.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1590/0074-0276140156